RNA template-mediated inhibition of hepatitis C virus RNA-dependent RNA polymerase activity. 2008

Ying-Kai Wang, and Karen L Rigat, and Jin-Hua Sun, and Min Gao, and Susan B Roberts
Department of Virology, Bristol Myers Squibb Co., Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, CT 06492, USA. ying-kai.wang@bms.com

The enzymatic activity of hepatitis C virus (HCV) RNA-dependent RNA polymerase NS5B is modulated by the molar ratio of NS5B enzyme and RNA template. Depending on the ratio, either template or enzyme can inhibit activity. Inhibition of NS5B activity by RNA template exhibited characteristics of substrate inhibition, suggesting the template binds to a secondary site on the enzyme forming an inactive complex. Template inhibition was modulated by primer. Increasing concentrations of primer restored NS5B activity and decreased the affinity of template for the secondary site. Conversely, increasing template concentration reduced the affinity of primer binding. The kinetic profiles suggest template inhibition results from the binding of template to a site that interferes with primer binding and the formation of productive replication complexes.

UI MeSH Term Description Entries
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D012313 RNA A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) RNA, Non-Polyadenylated,Ribonucleic Acid,Gene Products, RNA,Non-Polyadenylated RNA,Acid, Ribonucleic,Non Polyadenylated RNA,RNA Gene Products,RNA, Non Polyadenylated
D017361 Viral Nonstructural Proteins Proteins encoded by a VIRAL GENOME that are not structural components of VIRUS PARTICLES. Some of these proteins may play roles within the infected cell during VIRUS REPLICATION or act in regulation of virus replication or VIRUS ASSEMBLY. Nonstructural Proteins, Viral,NS Proteins, Viral,Viral NS Proteins,Viral Non-Structural Proteins,Viral Nonstructural Protein,Viral Nonstructural Proteins NS1,Viral Nonstructural Proteins NS2,Nonstructural Protein, Viral,Viral Non Structural Proteins

Related Publications

Ying-Kai Wang, and Karen L Rigat, and Jin-Hua Sun, and Min Gao, and Susan B Roberts
January 2013, Proceedings of the National Academy of Sciences of the United States of America,
Ying-Kai Wang, and Karen L Rigat, and Jin-Hua Sun, and Min Gao, and Susan B Roberts
August 2001, Archives of virology,
Ying-Kai Wang, and Karen L Rigat, and Jin-Hua Sun, and Min Gao, and Susan B Roberts
October 2003, Journal of virological methods,
Ying-Kai Wang, and Karen L Rigat, and Jin-Hua Sun, and Min Gao, and Susan B Roberts
April 2010, The Journal of biological chemistry,
Ying-Kai Wang, and Karen L Rigat, and Jin-Hua Sun, and Min Gao, and Susan B Roberts
January 2000, Current topics in microbiology and immunology,
Ying-Kai Wang, and Karen L Rigat, and Jin-Hua Sun, and Min Gao, and Susan B Roberts
January 1999, Methods in molecular medicine,
Ying-Kai Wang, and Karen L Rigat, and Jin-Hua Sun, and Min Gao, and Susan B Roberts
December 2000, Journal of virology,
Ying-Kai Wang, and Karen L Rigat, and Jin-Hua Sun, and Min Gao, and Susan B Roberts
March 2006, Infectious disorders drug targets,
Ying-Kai Wang, and Karen L Rigat, and Jin-Hua Sun, and Min Gao, and Susan B Roberts
January 1996, Methods in enzymology,
Ying-Kai Wang, and Karen L Rigat, and Jin-Hua Sun, and Min Gao, and Susan B Roberts
April 2004, Journal of medicinal chemistry,
Copied contents to your clipboard!